Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
5.97M
-
Shares change
-
-168K
-
Total reported value, excl. options
-
$46.7M
-
Value change
-
-$1.77M
-
Number of buys
-
13
-
Number of sells
-
-16
-
Price
-
$7.83
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q2 2019
41 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q2 2019.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.97M shares
of 13.8M outstanding shares and own 43.12% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (2.01M shares), NEA Management Company, LLC (1.56M shares), VANGUARD GROUP INC (265K shares), CADENCE CAPITAL MANAGEMENT LLC (264K shares), RENAISSANCE TECHNOLOGIES LLC (181K shares), DIMENSIONAL FUND ADVISORS LP (155K shares), WELLS FARGO & COMPANY/MN (149K shares), INGALLS & SNYDER LLC (146K shares), PERKINS CAPITAL MANAGEMENT INC (143K shares), and ESSEX INVESTMENT MANAGEMENT CO LLC (138K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.